NEW YORK, July 9, 2011 /PRNewswire/ -- The acquisition of the da Vinci Robotic Si Surgical System, a state-of-the-art robotic surgical technology, was recently announced by the Asian Heart Institute (AHI) in Mumbai, India. This marks the first of the new da Vinci Si models to be obtained by a hospital in Asia. This da Vinci model improves visualization with high definition 3D and beneficial changes to the user interface. The robot provides minimally invasive surgical treatment options for a number of medical disciplines including urology, cardiology, gynecology and general surgery.
Dr. David B. Samadi, Vice Chairman, Department of Urology, Chief of Robotics and Minimally Invasive Surgery at The Mount Sinai Medical Center, is supportive of the acquisition of surgical robot systems around the world, saying, "It is a positive development when a country like India can take advantage of technology such as the da Vinci Si Robotic Surgical System. The benefits that robotic surgery can present to a patient are numerous and, in many cases, life-saving."
Dr. Samadi, an expert in robotic prostate surgery, has been actively involved in bringing robotic surgery expertise to many countries. "Over the past year I've made efforts to raise awareness of the use of robotics in the treatment of prostate cancer, while extolling its benefits in other disciplines as well," said Samadi. "During that time I've participated in discussions, conferences, and TV interviews in the Dominican Republic. I have also traveled to Israel several times to perform live, televised robotic prostatectomy surgeries while demonstrating my SMART (Samadi Modified Advanced Robotic Technique) surgery method. The addition of the latest robotic surgical system in India indicates an awareness of its value as a new treatment method in the fight against prostate cancer and other diseases."
Having performed over 3,300 successful robotic prostatectomy procedures, Dr. Samadi receives patients from all over the world seeking his expertise. On the subject of medical travel, Dr. Samadi states, "There has been a trend towards patients travelling abroad to receive surgical treatments, primarily because of the high cost of medical care in the United States. The growing use of robotics in other countries can offer patients the same level of technology they could find at home." He concluded, though, "In the case of life-threatening diseases such as prostate cancer, finding the most experienced and qualified surgeon are paramount to the success of the procedure. The complicated nature of robotic prostate surgery, the learning curve involved with the use of the robot, and the number of procedures performed by the surgeon is very important. When a patient decides to travel for surgical treatment, whether from the United States to India or Israel or any other country, it's essential to make the quality of your treatment, not cost, the most important factor when choosing a surgeon."
As a service to his international patients, Dr. Samadi's website, RoboticOncology.com, has been made available in seven languages including: English, Spanish, German, Italian, French, Russian, and most recently, Hebrew. A section of RoboticOncology.com is dedicated to the needs of international patients who wish to learn more about the medical travel process.
For more information, please view the following links: